MMJ International Holdings: Marijuana Rescheduling or Regulatory Failure? D.C. Appellate Court Will Rule

"As DEA rescheduling cases merge and federal hemp litigation moves to the D.C. Circuit, MMJ argues that companies following FDA rules should not be disadvantaged while non-FDA-approved cannabinoid ...